skip to Main Content

2019 AICD Governance and Performance Study

This is the tenth year of the AICD NFP Governance and Performance Study.  This is the world's largest longitudinal study of governance and has been undertaken by BaxterLawley for the last eight years.

2016 AICD Not-for-profit Governance and Performance Study

For the fifth year, BaxterLawley has undertaken the NFP Governance and Performance Study with the Australian Institute of Company Directors.  This research is sponsored by the Commonwealth Bank and is the largest study of governance in Australia.  The 2016 study reveals, for the first time, the profit margins and targets of NFPs, and challenges director's expectations of financial performance.  We also examine performance measurement and the relationship between the NFP sector and governments.  The report was launched in Sydney by Susan Pascoe AM, Commissioner, Australian Charities and Not-for-profits Commission.

Strategic Planning

We were appointed by the board of this large professional services organisation to evaluate the financial and operating performance of the organisation, its operating environment and competitors. Constructed an evidence-based strategic plan for the next five years, then worked with staff to develop operational plans and KPIs.

Governance Evaluation

BaxterLawley undertook an evaluation of the current governance structures and processes for this $50m aged care provider, identified key risks and provided clear recommendations for improvement. All recommendations were subsequently implemented by the board.

Sustainable Funding & Contracting with NFPs 2013 – Department of Treasury

This report presents the results of the second annual evaluation of the Sustainable Funding and Contracting with the Not for Profit Sector (SFCNFP) Initiative and the Delivering Community Services in Partnership (DCSP) Policy reforms. This project involved quantitative and qualitative evaluation of the impact of reforms and identified areas of risk to the successful implementation of the policy.